Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al

Geahča maid

• Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
  Dahkki: Wilkins, B, et al.
  Almmustuhtton: (2008)
• Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
  Dahkki: Campbell, P, et al.
  Almmustuhtton: (2009)
• Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
  Dahkki: Beer, P, et al.
  Almmustuhtton: (2007)
• The medical research council PT1 trial in essential thrombocythemia.
  Dahkki: Green, A, et al.
  Almmustuhtton: (2004)
• Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
  Dahkki: Harrison, C, et al.
  Almmustuhtton: (2005)